缓控针植入穴位治疗功能性室性早搏临床观察

Clinical observation on point implantation of slowly-releasing medication for treatment of functional ventricular premature

目的:探求安全、有效的治疗功能性室性早搏的方法,研制具有高科技含量的新中药制剂。方法:将238例患者随机分为缓控针组(118例)、西药组(120例)。缓控针组采用补益宗气、滋阴安神中药验方制成缓控针新型制剂,利用套管针注射到肌肉(特定穴位)里,取穴为膻中、内关、心俞、脾俞、肺俞,缓释、控释药物并保持持久刺激;西药组采用口服心律平,每次150mg,每天3次。结果:缓控针组早搏的治愈率为51.7%,愈显率为71.2%,明显高于西药组的28.3%、50.8%(P<0.001)。结论:中药缓控针新制剂治疗功能性室性早搏疗效好,且安全性高,有良好的开发应用前景。

Objective TO probe into a safe and effective method for treatment of functional ventricular premature, and develop a new preparation of Chinese herbs with high science and technique contents. Methods Two hundred and thirty-eight cases were randomly divided into a slowly-releasing medication group （n=118） and a western medicine group （n = 120）, The slowly-control needle group were treated with intramuscular injection of slowly-releasing medication new type preparation made by proved recipe of Chinese herbs with replenishing and strengthening pectoral qi, and nourishing yin and tranquillization into Tanzhong （CV 17）, Neiguan （PC 6）, Xinshu （BL 15）, Pishu （BL 20） and Feishu （BL 13） by a trocar to slowly release and control releasing of the medicine so as to maintain lasting stimulation; the western medicine group with oral administration of Rythmol, thrice daily, 150 mg each time. Results The cured rate and the cured and markedly effective rate for the ventricular premature was 51.7% and 71.2 % in the slowly-releasing medication group, which were significantly higher than 28.3 % and 50. 8 % in the western medicine group （P^0. 001）. Conclusion The slowly-releasing medication new type preparation has a better therapeutic effect on functional ventricular premature, with high safety.